Cargando…

Tuberculosis-associated mortality in Shanghai, China: a longitudinal study

OBJECTIVE: To determine excess mortality in a cohort of people with tuberculosis in Shanghai. METHODS: Participants were local residents in 4 (of 19) districts in Shanghai, registered in one of four tuberculosis clinics between January 1, 2004 and December 31, 2008. Baseline data were collected at t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Weibing, Zhao, Qi, Yuan, Zhengan, Zheng, Yihui, Zhang, Yixing, Lu, Liping, Hou, Yun, Zhang, Yue, Xu, Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669732/
https://www.ncbi.nlm.nih.gov/pubmed/26668434
http://dx.doi.org/10.2471/BLT.15.154161
_version_ 1782404153922813952
author Wang, Weibing
Zhao, Qi
Yuan, Zhengan
Zheng, Yihui
Zhang, Yixing
Lu, Liping
Hou, Yun
Zhang, Yue
Xu, Biao
author_facet Wang, Weibing
Zhao, Qi
Yuan, Zhengan
Zheng, Yihui
Zhang, Yixing
Lu, Liping
Hou, Yun
Zhang, Yue
Xu, Biao
author_sort Wang, Weibing
collection PubMed
description OBJECTIVE: To determine excess mortality in a cohort of people with tuberculosis in Shanghai. METHODS: Participants were local residents in 4 (of 19) districts in Shanghai, registered in one of four tuberculosis clinics between January 1, 2004 and December 31, 2008. Baseline data were collected at the most recent diagnosis of tuberculosis and mortality was assessed between March and May of 2014. We calculated standardized mortality ratios (SMR) and case-fatality rates for all participants and for subgroups. Univariate and multivariate Cox regression models were used to quantify associations between co-morbidities and mortality from all causes and from tuberculosis. FINDINGS: We registered 4569 subjects in the cohort. Overall, the cohort had an SMR for deaths from all causes of 5.2 (95% confidence interval, CI: 4.8–5.6). Males had a higher SMR than females (6.1 versus 3.0). After adjustment for age and sex, hazard ratios (HR) for deaths from all causes were significantly greater in previously treated people (HR: 1.26; 95% CI: 1.08–1.49) and sputum smear-test positive people (HR: 1.55; 95% CI: 1.35–1.78). The risk of death from tuberculosis was also significantly greater for previously treated people (HR: 1.88; 95% CI: 1.24–2.86) and smear positive people (HR: 3.16; 95% CI: 2.06–4.87). CONCLUSION: People with tuberculosis in Shanghai have an increased risk of mortality. Earlier diagnosis and more vigilant follow-up may help to reduce mortality in this group.
format Online
Article
Text
id pubmed-4669732
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher World Health Organization
record_format MEDLINE/PubMed
spelling pubmed-46697322015-12-14 Tuberculosis-associated mortality in Shanghai, China: a longitudinal study Wang, Weibing Zhao, Qi Yuan, Zhengan Zheng, Yihui Zhang, Yixing Lu, Liping Hou, Yun Zhang, Yue Xu, Biao Bull World Health Organ Research OBJECTIVE: To determine excess mortality in a cohort of people with tuberculosis in Shanghai. METHODS: Participants were local residents in 4 (of 19) districts in Shanghai, registered in one of four tuberculosis clinics between January 1, 2004 and December 31, 2008. Baseline data were collected at the most recent diagnosis of tuberculosis and mortality was assessed between March and May of 2014. We calculated standardized mortality ratios (SMR) and case-fatality rates for all participants and for subgroups. Univariate and multivariate Cox regression models were used to quantify associations between co-morbidities and mortality from all causes and from tuberculosis. FINDINGS: We registered 4569 subjects in the cohort. Overall, the cohort had an SMR for deaths from all causes of 5.2 (95% confidence interval, CI: 4.8–5.6). Males had a higher SMR than females (6.1 versus 3.0). After adjustment for age and sex, hazard ratios (HR) for deaths from all causes were significantly greater in previously treated people (HR: 1.26; 95% CI: 1.08–1.49) and sputum smear-test positive people (HR: 1.55; 95% CI: 1.35–1.78). The risk of death from tuberculosis was also significantly greater for previously treated people (HR: 1.88; 95% CI: 1.24–2.86) and smear positive people (HR: 3.16; 95% CI: 2.06–4.87). CONCLUSION: People with tuberculosis in Shanghai have an increased risk of mortality. Earlier diagnosis and more vigilant follow-up may help to reduce mortality in this group. World Health Organization 2015-12-01 2015-09-28 /pmc/articles/PMC4669732/ /pubmed/26668434 http://dx.doi.org/10.2471/BLT.15.154161 Text en (c) 2015 The authors; licensee World Health Organization. This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.
spellingShingle Research
Wang, Weibing
Zhao, Qi
Yuan, Zhengan
Zheng, Yihui
Zhang, Yixing
Lu, Liping
Hou, Yun
Zhang, Yue
Xu, Biao
Tuberculosis-associated mortality in Shanghai, China: a longitudinal study
title Tuberculosis-associated mortality in Shanghai, China: a longitudinal study
title_full Tuberculosis-associated mortality in Shanghai, China: a longitudinal study
title_fullStr Tuberculosis-associated mortality in Shanghai, China: a longitudinal study
title_full_unstemmed Tuberculosis-associated mortality in Shanghai, China: a longitudinal study
title_short Tuberculosis-associated mortality in Shanghai, China: a longitudinal study
title_sort tuberculosis-associated mortality in shanghai, china: a longitudinal study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669732/
https://www.ncbi.nlm.nih.gov/pubmed/26668434
http://dx.doi.org/10.2471/BLT.15.154161
work_keys_str_mv AT wangweibing tuberculosisassociatedmortalityinshanghaichinaalongitudinalstudy
AT zhaoqi tuberculosisassociatedmortalityinshanghaichinaalongitudinalstudy
AT yuanzhengan tuberculosisassociatedmortalityinshanghaichinaalongitudinalstudy
AT zhengyihui tuberculosisassociatedmortalityinshanghaichinaalongitudinalstudy
AT zhangyixing tuberculosisassociatedmortalityinshanghaichinaalongitudinalstudy
AT luliping tuberculosisassociatedmortalityinshanghaichinaalongitudinalstudy
AT houyun tuberculosisassociatedmortalityinshanghaichinaalongitudinalstudy
AT zhangyue tuberculosisassociatedmortalityinshanghaichinaalongitudinalstudy
AT xubiao tuberculosisassociatedmortalityinshanghaichinaalongitudinalstudy